U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C17H25N3O5
Molecular Weight 351.3975
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ZOLEPRODOLOL

SMILES

COC1=NOC(COC2=CC=CC=C2OCC(O)CNC(C)(C)C)=N1

InChI

InChIKey=NXTODQHJOKDVFU-UHFFFAOYSA-N
InChI=1S/C17H25N3O5/c1-17(2,3)18-9-12(21)10-23-13-7-5-6-8-14(13)24-11-15-19-16(22-4)20-25-15/h5-8,12,18,21H,9-11H2,1-4H3

HIDE SMILES / InChI
Zoleprodolol was developed as an adrenoreceptor antagonist. Information about the current use of this compound is not available.

Approval Year

Name Type Language
ZOLEPRODOLOL
INN  
INN  
Official Name English
(±)-1-(2-((3-METHOXY-1,2,4-OXADIAZOL-5-YL)METHOXY)PHENOXY)-3-((TERT-BUTYLAMINO))PROPAN-2-OL
Systematic Name English
zoleprodolol [INN]
Common Name English
(±)-1-(2-((3-METHOXY-1,2,4-OXADIAZOL-5-YL)METHOXY)PHENOXY)-3-(TERT-BUTYLAMINO)PROPAN-2-OL
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C29576
Created by admin on Fri Dec 15 16:58:28 GMT 2023 , Edited by admin on Fri Dec 15 16:58:28 GMT 2023
Code System Code Type Description
SMS_ID
300000036845
Created by admin on Fri Dec 15 16:58:28 GMT 2023 , Edited by admin on Fri Dec 15 16:58:28 GMT 2023
PRIMARY
FDA UNII
95N3WB936T
Created by admin on Fri Dec 15 16:58:28 GMT 2023 , Edited by admin on Fri Dec 15 16:58:28 GMT 2023
PRIMARY
CAS
158599-53-2
Created by admin on Fri Dec 15 16:58:28 GMT 2023 , Edited by admin on Fri Dec 15 16:58:28 GMT 2023
PRIMARY
NCI_THESAURUS
C152961
Created by admin on Fri Dec 15 16:58:28 GMT 2023 , Edited by admin on Fri Dec 15 16:58:28 GMT 2023
PRIMARY
INN
9190
Created by admin on Fri Dec 15 16:58:28 GMT 2023 , Edited by admin on Fri Dec 15 16:58:28 GMT 2023
PRIMARY
PUBCHEM
133047
Created by admin on Fri Dec 15 16:58:28 GMT 2023 , Edited by admin on Fri Dec 15 16:58:28 GMT 2023
PRIMARY